Cite
HARVARD Citation
Rodrigo, M. et al. (2020). Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model. Biomaterials science. pp. 6246-6260. [Online].